RBM11 inhibitors are a class of chemical compounds that specifically target and inhibit the function of RBM11, an RNA-binding protein known for its role in regulating alternative splicing during post-transcriptional gene expression. RBM11, part of the RNA-binding motif (RBM) family, contains RNA recognition motifs (RRMs) that allow it to bind to pre-mRNA and influence the inclusion or exclusion of specific exons during splicing. This process is critical for generating multiple protein isoforms from a single gene, thereby increasing the diversity of the proteome. RBM11 is particularly involved in modulating splicing patterns in tissue-specific contexts, contributing to the differentiation and specialized function of cells. Inhibitors of RBM11 act by binding to its RNA-binding domains, preventing the protein from interacting with its target pre-mRNA sequences, thus disrupting its role in regulating splicing events.
The inhibition of RBM11 can lead to altered splicing patterns, which may significantly impact the expression of certain proteins that are crucial for cell function, growth, and differentiation. By blocking the regulatory activity of RBM11, these inhibitors interfere with the precise control of exon inclusion during mRNA processing, potentially leading to shifts in cellular behavior and protein synthesis. Researchers use RBM11 inhibitors to explore the specific roles of this protein in alternative splicing and to better understand how it contributes to gene expression regulation in different biological contexts. These inhibitors are valuable tools for studying the broader implications of RNA-binding proteins in cellular processes, as they help elucidate how splicing factors like RBM11 shape the proteome and influence cellular function. Additionally, studying RBM11 inhibitors provides insights into the complex regulatory networks that govern post-transcriptional gene expression, offering a deeper understanding of how cells adapt their protein output to meet specific functional demands during development and differentiation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
This compound may inhibit the deacetylation of histones at the RBM11 gene promoter, potentially leading to a tightly packed chromatin state that downregulates RBM11 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inducing DNA demethylation, this chemical could specifically lead to the hypomethylation of the RBM11 gene promoter, resulting in decreased levels of RBM11 transcription. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
This inhibitor might block DNA methyltransferases that typically methylate the promoter region of RBM11, thereby reducing the transcriptional activity of the RBM11 gene. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
By increasing histone acetylation, Suberoylanilide Hydroxamic Acid could compress the chromatin structure at the RBM11 locus, leading to decreased transcriptional initiation of the RBM11 gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid might repress transcription of the RBM11 gene through altered recruitment of retinoic acid receptors to the gene's regulatory regions, thereby reducing RBM11 levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
This mTOR inhibitor could selectively repress the translation of RBM11 mRNA by inhibiting downstream signaling pathways, leading to a reduction in RBM11 protein synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
By intercalating into DNA, Actinomycin D might directly block the transcription initiation complex of the RBM11 gene, leading to a significant decrease in RBM11 mRNA levels. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
As an inhibitor of RNA polymerase II, α-Amanitin could specifically hinder the transcription of the RBM11 gene, subsequently decreasing the production of RBM11 mRNA. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine may destabilize RBM11 mRNA by intercalating into its structure, leading to enhanced degradation and a consequent decrease in RBM11 protein levels. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
By inhibiting the recognition of acetylated lysine residues on histones, JQ1 could decrease the transcriptional activity of genes, including RBM11, resulting in lower expression. | ||||||